Breaking: Seattle attorney confirms an ongoing federal investigation into Susan Cox Powell case

AstraZeneca Q1 net profit plunges 31 percent

LONDON (AP) - British drug maker AstraZeneca PLC, facing generic competition for some of its biggest products, says first-quarter profits fell 31 percent.

The company also announced Thursday that it has received a subpoena from legal authorities in Massachusetts.

Net profit for the three months to March 31 was $1.01 billion, down from $1.63 billion a year earlier.

Revenue was 13 percent lower at $6.39 billion. The company said generic competition for bipolar medication Seroquel IR, hypertension drug Atacand and cholesterol drug Crestor drove revenue down.

The company said it received a subpoena March 28 from the U.S. attorney's office in Boston seeking documents relating to standards at its facility in Macclesfield, northwest England. It did not give further details.

AstraZeneca shares fell 1.8 percent to 33.28 pounds on the London Stock Exchange.


(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
Top Stories

  • One
    Microsoft calls its new Xbox 'truly intelligent TV'

  • Nature's Reality Check
    We can conquer terrorism, cure cancer, but a tornado can remind us of our insecurity

  • Back to Work
    Ten observations from practice that only a backup, middle child, left-handed QB can provide
MyNorthwest.com - Purpose of Comments statement
Bonneville Media encourages site users to express their opinions by posting comments. Our goal is to maintain a civil dialogue in which readers feel comfortable. At times, the comments can descend to personal attacks. Please do not engage in such behavior. We encourage your thoughtful comments which: have a positive and constructive tone, are on topic, are respectful toward others and their opinions. Bonneville reserves the right to remove comments which do not conform to these criteria.

Comments